a
2021
ANABOLIC EFFECT OF LNA043, A NOVEL DISEASE-MODIFYING OSTEOARTHRITIS DRUG CANDIDATE: RESULTS FROM AN IMAGING-BASED PROOF-OF-CONCEPT TRIAL IN PATIENTS WITH FOCAL ARTICULAR CARTILAGE LESIONS
TRATTNIG, S, C SCOTTI, D LAURENT, V JURAS, S HACKER et. al.
Autoři
TRATTNIG, S, C SCOTTI, D LAURENT, V JURAS, S HACKER, B COLE, Libor PAŠA, R LEHOVEC, P SZOMOLANYI, E RAITHEL, F SAXER, J PRAESTGAARD, Gamba F LA, JL JIMENEZ, DS RAMOS, R ROUBENOFF a M SCHIEKER